Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco van Doorn

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Plos One|April 9, 2020
Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expressionCatarina Salgado, Celine Roelse, Rogier Nell, et al.
Experimental Dermatology|October 27, 2022
Stratum corneum cytokine levels in mycosis fungoidesAnh Ly Nguyen, Sanja Kezic, Maarten Vermeer, et al.
Seminars in Oncology|October 8, 2005
Aberrant DNA methylation in cutaneous malignanciesRemco van Doorn, Nelleke A Gruis, Rein Willemze, et al.
Cancer Research|October 3, 2002
A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphomaRemco van Doorn, Remco Dijkman, Maarten H Vermeer, et al.
JAAD Case Reports|December 5, 2018
Remission of psoriasis during treatment with sorafenibMarloes S van Kester, Saskia A C Luelmo, Maarten H Vermeer, et al.
The Lancet. Infectious Diseases|August 29, 2018
A recurrent migratory swellingRachel E J Roach, Remco van Doorn, Francisca T de Bruïne, et al.
The EMBO Journal|March 31, 2011
Antagonistic TSC22D1 variants control BRAF(E600)-induced senescenceCornelia Hömig-Hölzel, Remco van Doorn, Celia Vogel, et al.
Journal of the American Academy of Dermatology|November 20, 2022
Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the NetherlandsJiahe Vermariën-Wang, Thom Doeleman, Remco van Doorn, et al.
The Journal of Investigative Dermatology|April 3, 2020
Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM SyndromeEirini Christodoulou, Rogier J Nell, Rob M Verdijk, et al.
Scientific Reports|April 4, 2024
Reassessing human MHC-I genetic diversity in T cell studiesRoderick C Slieker, Daniël O Warmerdam, Maarten H Vermeer, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Plos One|April 9, 2020
Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expressionCatarina Salgado, Celine Roelse, Rogier Nell, et al.
Experimental Dermatology|October 27, 2022
Stratum corneum cytokine levels in mycosis fungoidesAnh Ly Nguyen, Sanja Kezic, Maarten Vermeer, et al.
Seminars in Oncology|October 8, 2005
Aberrant DNA methylation in cutaneous malignanciesRemco van Doorn, Nelleke A Gruis, Rein Willemze, et al.
Cancer Research|October 3, 2002
A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphomaRemco van Doorn, Remco Dijkman, Maarten H Vermeer, et al.
JAAD Case Reports|December 5, 2018
Remission of psoriasis during treatment with sorafenibMarloes S van Kester, Saskia A C Luelmo, Maarten H Vermeer, et al.
The Lancet. Infectious Diseases|August 29, 2018
A recurrent migratory swellingRachel E J Roach, Remco van Doorn, Francisca T de Bruïne, et al.
The EMBO Journal|March 31, 2011
Antagonistic TSC22D1 variants control BRAF(E600)-induced senescenceCornelia Hömig-Hölzel, Remco van Doorn, Celia Vogel, et al.
Journal of the American Academy of Dermatology|November 20, 2022
Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the NetherlandsJiahe Vermariën-Wang, Thom Doeleman, Remco van Doorn, et al.
The Journal of Investigative Dermatology|April 3, 2020
Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM SyndromeEirini Christodoulou, Rogier J Nell, Rob M Verdijk, et al.
Scientific Reports|April 4, 2024
Reassessing human MHC-I genetic diversity in T cell studiesRoderick C Slieker, Daniël O Warmerdam, Maarten H Vermeer, et al.
Pageof 12